Nonsteroidal Antiinflammatory Drugs, Cyclooxygenase-2, and the Kidneys

被引:18
|
作者
Rahman, Saadur [1 ]
Malcoun, Anthony [2 ,3 ]
机构
[1] Michigan State Univ, Garden City Hosp, Davenport, IA 52806 USA
[2] St John Macomb Hosp, St John Hlth Syst, Nephrol Fellowship Program, Warren, MI 48093 USA
[3] Hypertens Nephrol Associate, PC, Livonia, MI USA
来源
PRIMARY CARE | 2014年 / 41卷 / 04期
关键词
NSAIDS; COX-1; COX-2; Kidneys; Hypertension; Acute kidney injury; Electrolytes; Glomerular filtration rate; ACUTE INTERSTITIAL NEPHRITIS; ACUTE-RENAL-FAILURE; BLOOD-PRESSURE; NEPHROTIC SYNDROME; HYPERTENSIVE PATIENTS; INHIBITORS; RISK; PROSTAGLANDIN; THERAPY; DISEASE;
D O I
10.1016/j.pop.2014.09.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nonsteroidal antiinflammatory drugs (NSAIDs) are one of the most commonly used classes of medications in the world, which function by inhibiting the cyclooxygenase (COX) enzymes and downregulating the inflammatory pathway. COX enzymes are constitutively expressed in the kidneys and function to maintain a homeostatic environment in terms of maintaining the glomerular filtration rate, blood pressure, sodium, water, and osmotic regulation. When the COX enzymes are inhibited by NSAIDs, a multitude of renal and vascular complications occur. This article aims to enlighten primary care physicians of the complications that arise with NSAIDs from a renal perspective and to present some management strategies.
引用
收藏
页码:803 / +
页数:20
相关论文
共 50 条
  • [1] Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and colorectal cancer prevention
    DuBois, RN
    CURRENT OPINION IN GASTROENTEROLOGY, 2001, 17 (01) : 65 - 71
  • [2] The Role of Nonsteroidal Antiinflammatory Drugs and Cyclooxygenase-2 Inhibitors on Experimental Colitis
    Ribeiro Paiotti, Ana Paula
    Marchi, Patricia
    Miszputen, Sender Jankiel
    Fujiyama Oshima, Celina Tizuko
    Franco, Marcello
    Ribeiro, Daniel Araki
    IN VIVO, 2012, 26 (03): : 381 - 393
  • [3] The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain
    Sciulli, MG
    Capone, ML
    Tacconelli, S
    Patrignani, P
    PHARMACOLOGICAL REPORTS, 2005, 57 : 66 - 85
  • [4] Gastrointestinal Safety of Nonsteroidal Antiinflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors in Patients on Warfarin
    Cheetham, T. Craig
    Levy, Gerald
    Niu, Fang
    Bixler, Felicia
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (11) : 1765 - 1773
  • [5] The perioperative use of cyclooxygenase-2 selective nonsteroidal antiinflammatory drugs may offer a safer alternative
    Reuben, SS
    Connelly, NR
    ANESTHESIOLOGY, 2004, 100 (03) : 748 - 748
  • [6] Crossreactive cutaneous hypersensitivity to nonsteroidal Antiinflammatory drugs -: Are preferential cyclooxygenase-2 inhibitors a therapeutic option?
    Sanchez-Borges, Mario
    Capriles-Hulett, Arnaldo
    Caballero-Fonseca, Fernan
    ALLERGY & CLINICAL IMMUNOLOGY INTERNATIONAL-JOURNAL OF THE WORLD ALLERGY ORGANIZATION, 2007, 19 (03): : 91 - 94
  • [7] Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages
    BarriosRodiles, M
    Keller, K
    Belley, A
    Chadee, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) : 896 - 900
  • [8] Risk of Upper Gastrointestinal Complications Associated with Cyclooxygenase-2 Selective and Nonselective Nonsteroidal Antiinflammatory Drugs
    Castellsague, Jordi
    Holick, Crystal N.
    Hoffman, Clorinda C.
    Gimeno, Victoria
    Stang, Mary-Rose
    Perez-Gutthann, Susana
    PHARMACOTHERAPY, 2009, 29 (12): : 1397 - 1407
  • [9] Nonsteroidal antiinflammatory drugs: A new generation of cyclooxygenase inhibitors
    Beuck, M
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1999, 38 (05) : 631 - 633
  • [10] NECROSES OF THE KIDNEYS BY NONSTEROIDAL ANALGESIC ANTIINFLAMMATORY DRUGS (NSAIDS)
    BEUTER, W
    TIERARZTLICHE UMSCHAU, 1986, 41 (07): : 474 - &